Netherlands· NL-c1cbad095aca
Cyclogest 400 mg, ovule
A progesterone product containing progesteron, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 15 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Progesterone is registered in 15 of 19 countries.
Countries holding a registration under ATC G03DA04 (progesterone), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Progesterone · ATC G03DA04
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of progesterone costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.57 in Italy to $1.52 in Switzerland — a ×2.7 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Progesterone · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.52
- IT Italy$0.57
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- PROGESTERON
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- G03DA04
- ATC class
- Progesterone
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id134540//118749
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
216 interactions on record for progesterone.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Progesterone · interactions on record
216 records
- 2 severe
- 122 moderate
- 1 minor
- 91 info
Most severe, free to view
- EdoxabanB01AF03severe
- VenetoclaxL01XX52severe
- ClotrimazoleA01AB18moderate
- AprepitantA04AD12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Progesterone in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAmelgen 400 mg VagitoriumEbb Medical AB
- NorwayAmelgen2care4 ApS
- PolandCyclogestDelfarma Sp. z o.o.
- United KingdomCyclogest 400mg pessariesL.D. Collins & Co. Ltd
- SpainCYCLOGEST 400 MG OVULOSGedeon Richter Plc.
- IrelandProgesterone 400 mg pessariesGedeon Richter Plc
- FinlandCyclogestGedeon Richter Plc
- FranceAMELGEN 400 mg, ovuleGEDEON RICHTER ( HONGRIE)
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Arefam, Cyclogest
- Belgium · Amelgen, Gepretix
- Bulgaria · Prolutex, Кринон
- Cyprus · Cyclogest, Prolutex
- Czechia · Agolutin, Amelgen
- Germany · Crinone, Cyclogest
- Denmark · Crinone, Cyclogest
- Estonia · Amelgen, Crinone
- Spain · Cyclogest, Darstin
- Finland · Crinone, Cyclogest
- France · Amelgen, Crinone
- United Kingdom (Northern Ireland) · Crinone, Gepretix
- Greece · Crinone, Cyclogest
- Croatia · Crinone, Cyclogest
- Hungary · Crinone, Cyclogest
- Ireland · Crinone, Lubion
- Iceland · Crinone, Cyclogest
- Italy · Amelgen, Crinone
- Lithuania · Crinone, Gepretix
- Luxembourg · Amelgen, Inprosub
- Latvia · Amelgen, Crinone
- Malta · Cyclogest, Seidigestan
- Norway · Crinone, Cyclogest
- Poland · Crinone, Cyclogest
- Portugal · Cyclogest, Folac
- Romania · Arefam, Crinone
- Sweden · Crinone, Cyclogest
- Slovenia · Amelgen, Crinone
- Slovakia · Agolutin, Agolutin Depot
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5583e94-bce4-480d-b5b3-7091c133b72c GET /v1/drugs/f5583e94-bce4-480d-b5b3-7091c133b72c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Ovule",
"route": "Vaginaal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h118749_smpc.pdf",
"strength": null,
"atc_label": "Progesterone",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134540",
"excipients": [
"HARD VET"
],
"substances": [
"PROGESTERON"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134540.pdf",
"authorised_at": "2025/01/14",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "134540//118749",
"additional_monitoring": "N"
}See everything about progesterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.